Rivenprost (drug) (DrugBank: Rivenprost)
1 disease| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 97 | Ulcerative colitis | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00296556 (ClinicalTrials.gov) | February 2006 | 24/2/2006 | Therapeutic Study of ONO-4819CD for Ulcerative Colitis | A Randomized, Placebo-Controlled Trial of ONO-4819CD for Treatment of Mild to Moderate Ulcerative Colitis. | Ulcerative Colitis | Drug: Rivenprost (drug) | Kyoto University, Graduate School of Medicine | National Institute of Biomedical Innovation | Terminated | 20 Years | N/A | Both | 7 | Phase 2 | Japan |